In The News Posted February 5, 2019 Share Posted February 5, 2019 ChinaEquity Group wird Hauptaktionär von RBC MALVERN, Pennsylvania und PEKING, 5. Februar 2019 /PRNewswire/ -- Reaction Biology Corporation (www.reactionbiology.com) („RBC") und die ChinaEquity Group (www.chinaequity.net) („CEG") gaben heute den Abschluss einer Aktientauschtransaktion... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.